Free Trial

Atossa Therapeutics (ATOS) SEC Filings & 10K Form

Atossa Therapeutics logo
$1.20 -0.08 (-6.25%)
(As of 11/20/2024 ET)

Recent Atossa Therapeutics SEC Filings

DateFilerForm TypeView
11/12/2024
12:32 PM
Atossa Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:27 AM
Atossa Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
5:35 AM
Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
2:24 PM
Atossa Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
08/12/2024
8:00 AM
Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
8:05 AM
Atossa Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/23/2024
11:15 PM
Atossa Therapeutics (Filer)
Form EFFECT
05/23/2024
8:00 AM
Atossa Therapeutics (Filer)
Form DEF 14A
05/14/2024
3:46 PM
Atossa Therapeutics (Filer)
Form DEL AM
05/13/2024
8:00 AM
Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
8:05 AM
Atossa Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
8:00 AM
Atossa Therapeutics (Filer)
Form PRE 14A
05/10/2024
8:04 AM
Atossa Therapeutics (Filer)
Form ARS
03/18/2024
7:35 AM
Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2024
7:30 PM
Atossa Therapeutics (Issuer)
Cigler Tessa (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/14/2024
7:35 PM
Atossa Therapeutics (Issuer)
Cigler Tessa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:30 AM
Atossa Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ATOS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners